CK Life Sciences International Holdings has a current ratio of 0.87. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If CK Life Sciences International Holdings has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
FRA:LSI's Current Ratio is ranked worse than 86.23% of 1416
companies
in the Biotechnology industry
Industry Median: 3.885
vs FRA:LSI: 0.87
CK Life Sciences International Holdings (FRA:LSI) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
CK Life Sciences International Holdings Current Ratio Related Terms
CK Life Sciences International Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings Current Ratio Chart
CK Life Sciences International Holdings Annual Data
FRA:LSI vs VRTX, REGN, ALNY: Current Ratio Comparison
For the Biotechnology subindustry, CK Life Sciences International Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CK Life Sciences International Holdings Current Ratio vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings (FRA:LSI) has a Current Ratio of 0.87 as of Dec. 2025. This is 36% below median its historical median of 1.35. Over the past decade, CK Life Sciences International Holdings' Current Ratio has ranged from 0.70 to 3.60. According to the industry distribution chart, CK Life Sciences International Holdings ranks #1221 out of 1416 companies in the Biotechnology industry, placing it in the top 86.2%.
Is CK Life Sciences International Holdings' Current Ratio too high?
CK Life Sciences International Holdings' current Current Ratio of 0.87 is 36% below median its 10-year median of 1.35. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 3.60. The Biotechnology industry median Current Ratio is 3.89. CK Life Sciences International Holdings' value of 0.87 is 77.6% below this industry median. Based on the distribution chart, CK Life Sciences International Holdings ranks #1221 out of 1416 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CK Life Sciences International Holdings ranks #1221 out of 1416 companies for Current Ratio. This places CK Life Sciences International Holdings in the lower half of its industry. The industry median Current Ratio is 3.89. CK Life Sciences International Holdings' value of 0.87 is 77.6% below this benchmark. Historically, CK Life Sciences International Holdings' own Current Ratio has ranged from 0.70 to 3.60 over the past decade. While the company's 10-year median is 1.35 vs. the industry median of 3.89, CK Life Sciences International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CK Life Sciences International Holdings's current Current Ratio of 0.87 is 77.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CK Life Sciences International Holdings's current Current Ratio is 0.87, which is 36% below median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (FRA:LSI) has a current Current Ratio of 0.87. The stock's GF Value™ is €0.08, compared to a current price of €0.06 — trading 20% below its estimated fair value. The current Current Ratio is 0.87, which is 36% below median its 10-year median of 1.35 and 77.6% below the Biotechnology industry median of 3.89. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For CK Life Sciences International Holdings (FRA:LSI), the current Current Ratio is 0.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CK Life Sciences International Holdings (FRA:LSI) Overvalued in 2026?
Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued.
The current stock price of €0.06 is trading 20% below its estimated GF Value™ of €0.08.
Key valuation signals for FRA:LSI:
Current Ratio: 0.87 (36% below median its 10-year median of 1.35)
GF Value™: €0.08 vs. price of €0.06 (20% below fair value)
Industry Position: 77.6% below the Biotechnology median (#1221 of 1416)
No single metric tells the full story. See the FRA:LSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CK Life Sciences International Holdings Business Description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score
Get the complete analysis for FRA:LSI
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LSI has been successfully added to your 
